Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS) [Phase 4]
Phase 4 clinical trial evaluating quality of life in subjects with highly active relapsing multiple sclerosis; study completed with results …
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 [Phase 3]
Phase 3 trial exploring ocrelizumab's effect on brain innate immune microglial activation in multiple sclerosis using PET-MRI.
-
CLINICAL_TRIALS trial_result · 2023-08-28Clinical Trial Update: Efficacy and Safety of BG00012 in MS [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of BG00012 in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Combined Effect of Transcranial Direct Current Stimulation (tDCS) and Physical Activity on Gait and Functional Mobility in Participants With Multiple Sclerosis [NA]
A completed clinical trial evaluating the combined effect of transcranial direct current stimulation (tDCS) and physical activity on gait an…
-
CLINICAL_TRIALS trial_result · 2023-07-28Clinical Trial Update: Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). [Phase 2, Phase 3]
Clinical trial update for cladribine vs placebo in non-active progressive multiple sclerosis (CLASP-MS) is currently recruiting in Phase 2 a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients [Phase 3]
Phase 3 trial assessing safety and tolerability of converting relapsing multiple sclerosis patients from oral, injectable, or infusion disea…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Mesenchymal Stem Cells for Multiple Sclerosis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating mesenchymal stem cells for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the effects of physical therapy and dalfampridine on functional mobility in non-ambulatory people with…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: e-Mobile Tablet for People With Chronic Conditions [NA]
Clinical trial update for an e-Mobile Tablet intervention in chronic conditions; the study is completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS [Phase 3]
Non-inferiority Phase 3 trial comparing rituximab to ocrelizumab in relapsing multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: A Trial of Neuroprotection With ACTH in Acute Optic Neuritis [Phase 4]
Phase 4 clinical trial update on neuroprotection with ACTH in acute optic neuritis for multiple sclerosis, terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis [Phase 3]
Phase 3 trial comparing sequential mitoxantrone and interferon versus interferon alone in patients with high progression risk in early multi…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Minocycline in MS: Confirmation of Benefit [Phase 3]
Phase 3 trial investigating minocycline for multiple sclerosis and clinically isolated syndrome; the study is terminated after completion.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period [Phase 3]
Phase 3 extension study evaluating long-term safety of teriflunomide 14 mg daily in patients with a first clinical episode suggestive of mul…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients [Phase 2]
Phase 2 clinical trial investigating repurposing metformin to improve therapeutic outcomes in patients with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome [Phase 3]
A Phase 3 randomized, double-blind trial evaluating teriflunomide in radiologically isolated syndrome for multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update for intranasal insulin in multiple sclerosis across Phase 1 and Phase 2 has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis [Phase 2]
Phase 2 trial investigating belimumab added to B-cell depletion in relapsing-remitting multiple sclerosis was terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis [Phase 2]
Phase 2 clinical trial on augmenting cerebral blood flow to treat established multiple sclerosis has been terminated; results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the efficacy and safety of BCD-033 and Rebif for multiple sclerosis has posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: tDCS and Glucose Uptake in Leg Muscles [NA]
Clinical trial on transcranial direct current stimulation (tDCS) and glucose uptake in leg muscles for multiple sclerosis has completed with…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Methylprednisolone During the Switch Between Natalizumab and Fingolimod [Phase 4]
Phase 4 clinical trial update on methylprednisolone during the switch from natalizumab to fingolimod in multiple sclerosis patients.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue [Phase 4]
Phase 4 clinical trial evaluating cognitive behavioral therapy, modafinil, or both for fatigue in people with multiple sclerosis; completed …
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Transcranial Direct Current Stimulation and Walking in Multiple Sclerosis [NA]
Clinical trial update on transcranial direct current stimulation and walking in multiple sclerosis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis [Phase 4]
Phase 4 trial update examining teriflunomide concentration in serum and cerebrospinal fluid of patients with multiple sclerosis.